Company intelligence
Merieux Equity Partners
Invested Investors
About Merieux Equity Partners
Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner registered with the French Financial Markets Authority (Autorité des Marchés Financiers, AMF), Merieux Equity Partners currently manages 5 main funds representing €2 billion in assets under management, and has supported over 60 companies in Venture Capital and Growth/Buyout across Europe and North America since its creation. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plans, offering them privileged access to our sector expertise and cross-border experience. With a team of 28 full-time employees and 6 Senior Advisors, we strive to bring the best of our operational experience and privileged access to Merieux's industrial network.
Verified activity
Signals from Merieux Equity Partners
3 published signals
Presence & Recognition
Merieux Equity Partners will represent at IPEM Global 2026 from September 8 to 10 at the Palais des Congrès in Paris.
Reported by Merieux Equity Partners
Strategy & Corporate Development
Merieux Equity Partners announced the full exit of its stake in MIMETAS, now majority owned by Bruker Corporation.
Reported by Merieux Equity Partners
Strategy & Corporate Development
Merieux Equity Partners completed the majority acquisition of OMX portfolio company MIMETAS by Bruker.
Reported by Kristin Thompson